Vanguard Group’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.31B | Sell |
|
|||||
|
2025
Q1 | $1.14B | Sell |
|
|||||
|
2024
Q4 | $953M | Sell |
|
|||||
|
2024
Q3 | $1.06B | Sell |
|
|||||
|
2024
Q2 | $1B | Buy |
|
|||||
|
2024
Q1 | $1.14B | Sell |
|
|||||
|
2023
Q4 | $1.07B | Sell |
|
|||||
|
2023
Q3 | $1.07B | Buy |
|
|||||
|
2023
Q2 | $1.19B | Buy |
|
|||||
|
2023
Q1 | $1.37B | Buy |
|
|||||
|
2022
Q4 | $1.41B | Buy |
|
|||||
|
2022
Q3 | $1.4B | Buy |
|
|||||
|
2022
Q2 | $1.38B | Buy |
|
|||||
|
2022
Q1 | $1.24B | Buy |
|
|||||
|
2021
Q4 | $1.18B | Sell |
|
|||||
|
2021
Q3 | $1.09B | Buy |
|
|||||
|
2021
Q2 | $998M | Buy |
|
|||||
|
2021
Q1 | $982M | Buy |
|
|||||
|
2020
Q4 | $92M | Buy |
|
|||||
|
2020
Q3 | $59.4M | Buy |
|
|||||
|
2020
Q2 | $67.2M | Buy |
|